These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23844640)

  • 1. Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.
    Twiss J; McKenna S; Ganderton L; Jenkins S; Ben-L'amri M; Gain K; Fowler R; Gabbay E
    BMC Pulm Med; 2013 Jul; 13():45. PubMed ID: 23844640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Cima K; Twiss J; Speich R; McKenna SP; Grünig E; Kähler CM; Ehlken N; Treder U; Crawford SR; Huber LC; Ulrich S
    Health Qual Life Outcomes; 2012 Sep; 10():110. PubMed ID: 22971041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Polish adaptation of the CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Małaczynska-Rajpold K; Smukowska-Gorynia A; Heaney A; McKenna SP; Janus M; Araszkiewicz A; Jankiewicz S; Slawek-Szmyt S; Tomaszewska I; Mularek-Kubzdela T
    Cardiol J; 2020; 27(5):608-615. PubMed ID: 30338844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAPTATION AND VALIDATION OF THE CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW (CAMPHOR) FOR CROATIA.
    Hećimović A; Heaney A; McKenna SP; Basara L; Jakopović M; Vukić Dugac A; Redžepi G; Rotim C; Samaržija M; Jokić-Begić N; Popović-Grle S
    Acta Clin Croat; 2019 Mar; 58(1):3-12. PubMed ID: 31363319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.
    Ganderton L; Jenkins S; McKenna SP; Gain K; Fowler R; Twiss J; Gabbay E
    Respirology; 2011 Nov; 16(8):1235-40. PubMed ID: 21810146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.
    McKenna SP; Doughty N; Meads DM; Doward LC; Pepke-Zaba J
    Qual Life Res; 2006 Feb; 15(1):103-15. PubMed ID: 16411035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses.
    McKenna SP; Ratcliffe J; Meads DM; Brazier JE
    Health Qual Life Outcomes; 2008 Aug; 6():65. PubMed ID: 18718016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian.
    Coffin D; Duval K; Martel S; Granton J; Lefebvre MC; Meads DM; Twiss J; McKenna SP
    Can Respir J; 2008 Mar; 15(2):77-83. PubMed ID: 18354747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    Villaquirán C; Moreno S; Dueñas R; Acuña P; Lutz JR; Wilburn J; Heaney A
    J Bras Pneumol; 2019 Jul; 45(6):e20180332. PubMed ID: 31365733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Gomberg-Maitland M; Thenappan T; Rizvi K; Chandra S; Meads DM; McKenna SP
    J Heart Lung Transplant; 2008 Jan; 27(1):124-30. PubMed ID: 18187098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Use in Spain.
    Aguirre-Camacho A; Stepanous J; Blanco-Donoso LM; Moreno-Jiménez B; Wilburn J; González-Saiz L; McKenna SP
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):467-473. PubMed ID: 27989660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation and validation of the Cambridge pulmonary hypertension outcome review for Sweden.
    Selimovic N; Rundqvist B; Kjörk E; Viriden J; Twiss J; McKenna SP
    Scand J Public Health; 2012 Dec; 40(8):777-83. PubMed ID: 23117210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
    Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
    J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the adapted Dutch version of the revised Scoliosis Research Society 22-item questionnaire.
    Schlösser TP; Stadhouder A; Schimmel JJ; Lehr AM; van der Heijden GJ; Castelein RM
    Spine J; 2014 Aug; 14(8):1663-72. PubMed ID: 24360746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests of data quality, scaling assumptions, reliability, and construct validity of the SF-36 health survey in people who abuse heroin.
    Chiu EC; Hsueh IP; Hsieh CH; Hsieh CL
    J Formos Med Assoc; 2014 Apr; 113(4):234-41. PubMed ID: 24685299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the psychometric properties of the Swiss French version of the Older People's Quality of Life questionnaire (OPQOL-35-SF).
    Carrard S; Mooser C; Hilfiker R; Mittaz Hager AG
    Health Qual Life Outcomes; 2022 Mar; 20(1):43. PubMed ID: 35264182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH).
    Vergunst F; Jenkinson C; Burns T; Anand P; Gray A; Rugkåsa J; Simon J
    Health Qual Life Outcomes; 2017 Dec; 15(1):250. PubMed ID: 29282075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.